Key Highlights:

• Capital Adequacy Improvement: Post the capital infusion, UGRO Capital’s capital adequacy ratio is expected to enhance from 19.41% at the end of FY25 to 29.4%, providing substantial headroom for future growth.
• Rights Issue: In addition to the CCDs, the board has also approved a rights issue of up to ₹400 crore.
• Conversion Price: The new CCDs will be issued at a conversion price of ₹185 per share.

Previous Capital Raise:

In June 2024, UGRO Capital had successfully raised capital commitments totaling ₹1,265 crore, comprising ₹258 crore through CCDs and ₹1,007 crore via warrants. These instruments were issued at a conversion price of ₹264 per share.

Financial Performance:

As of FY25, UGRO Capital reported assets under management (AUM) of ₹12,003 crore, up from ₹9,047 crore in FY24. The company’s gross non-performing assets (GNPA) ratio stood at 2.3%, compared to 2% in the previous year.

Investor Participation:

The capital raise has garnered significant interest from institutional investors. Samena Capital and its private equity funds, currently holding a 7.49% stake, have committed up to ₹500 crore, positioning themselves as major institutional shareholders. Additionally, the Investment Fund for Developing Countries (IFU), a Danish impact investor, owns a 16.35% stake in UGRO Capital.

The post UGRO Capital to Raise Rs 915 Cr via CCD Issue appeared first on The India Bizz Startup News Website.

The post UGRO Capital to Raise Rs 915 Cr via CCD Issue appeared first on The India Bizz Startup News Website.